$357.27
+22.14% past month
Notable price movement
Oct 26, 2026
$357.27+3.45%
Comparable listed companies in commercial physical and biological research fell 1.00% on average, with 2 of 3 declining . The company rose 3.45%, so its gain was not shared by the cohort .
Oct 23, 2026
$345.37+1.68%
Comparable listed companies in commercial physical and biological research rose 0.55% on average, with two of three rising and one falling . CRL's 1.68% gain was larger than the cohort's average move, and the items hold no company-specific report for the day.
Oct 22, 2026
$339.66-1.51%
CRL fell 1.51% while comparable listed companies in commercial physical and biological research rose 0.80% on average, with two of three peers higher . The decline was therefore not shared by the group. Volume was 2.6x the trailing 20-session average, and the session ranged from 337.78 to 351.21 .
Oct 21, 2026
$344.87+9.33%
Comparable listed companies in physical and biological research services rose 2.33% on average, and 2 of 3 rose . This stock's 9.33% gain was far larger than the cohort's average move . Volume ran at 2.8x the trailing 20-session average, and the session range was 11.2% of the low .
Oct 20, 2026
$315.45+5.14%
Comparable listed companies in commercial physical and biological research rose 1.39% on average, with all three rising . This company's 5.14% gain was larger than the cohort's move.
Oct 19, 2026
$300.02-0.04%
Oct 16, 2026
$300.15-1.99%
Comparable listed companies in commercial physical and biological research fell 1.11% on average, with all 3 of 3 falling . The company's 1.99% decline came alongside that sector weakness and was somewhat larger than the cohort average .
Closing prices for CRL. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.